NASDAQ:CBAY
CymaBay Therapeutics Inc
- Stock
Last Close
32.47
21/03 20:00
Market Cap
3.73B
Beta: 0.26
Volume Today
8.35M
Avg: 1.67M
PE Ratio
−23.78
PFCF: −42.19
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 182K - | 1.18M 546.98% | 995.50K 15.46% | 604K - | 604K 0% | |||||||
average payables | 677K - | 1.39M 105.47% | 1.55M 11.18% | 953.50K 38.34% | 1.10M 15.89% | 1.64M 48.60% | 2.24M 36.30% | 1.37M 38.92% | 1.48M 8.23% | 1.91M 29.23% | 2.46M 28.77% | |
average receivables | 147.50K - | 262.50K 77.97% | 266.50K 1.52% | 93K 65.10% | 2.50M 2,588.17% | 2.50M 0% | 343.50K 86.26% | 482K 40.32% | 138.50K 71.27% | |||
book value per share | 1.32 - | 1.15 13.06% | 1.49 29.41% | 0.17 88.71% | 2.43 1,349.42% | 2.95 21.13% | 2.78 5.70% | 2.07 25.49% | 1.87 9.68% | 0.41 77.99% | 0.00 99.33% | |
capex per share | -0.01 - | -0.00 - | -0.00 56.82% | -0.01 1,082.98% | -0.00 48.65% | -0.00 93.51% | -0.00 301.68% | -0.00 37.67% | -0.00 99.75% | |||
capex to depreciation | -5.72 - | -1.45 - | -0.77 46.73% | -5.04 553.09% | -0.55 89.07% | -0.03 93.97% | -0.13 280.56% | -0.21 64.84% | -0.65 213.48% | |||
capex to operating cash flow | 0.00 - | 0.00 - | 0.00 23.53% | 0.01 600.16% | 0.00 66.59% | 0.00 85.41% | 0.00 166.87% | 0.00 40.48% | 0.01 248.55% | |||
capex to revenue | -0.00 - | -0.01 - | ||||||||||
cash per share | 2.22 - | 2.89 29.99% | 2.19 24.00% | 0.72 66.98% | 2.79 284.26% | 3.09 10.97% | 2.85 7.83% | 2.12 25.44% | 2.63 23.60% | 1.54 41.22% | 0.00 99.76% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 182.50 - | |||||||||||
debt to assets | 0.14 - | 0.12 12.06% | 0.22 79.65% | 0.45 110.33% | 0.06 87.13% | 0.01 - | 0.01 8.49% | 0.25 2,148.77% | 0.64 151.40% | 0.01 98.09% | ||
debt to equity | 0.24 - | 0.33 36.14% | 0.33 1.74% | 2.23 574.99% | 0.07 96.79% | 0.01 - | 0.01 5.92% | 0.39 3,075.03% | 2.51 548.12% | 0.02 99.28% | ||
dividend yield | ||||||||||||
earnings yield | -0.08 - | -0.27 238.63% | -0.49 80.41% | -0.66 35.25% | -0.09 86.95% | -0.16 85.82% | -0.78 387.98% | -0.12 84.18% | -0.39 213.24% | -0.22 43.98% | -0.00 99.98% | |
enterprise value | 106.62M - | 111.36M 4.44% | 33.54M 69.88% | 38.87M 15.87% | 304.16M 682.58% | 405.96M 33.47% | 108.67M 73.23% | 369.00M 239.57% | 165.94M 55.03% | 621.16M 274.32% | 2.51T 403,715.08% | |
enterprise value over ebitda | -11.59 - | -3.58 69.16% | -2.30 35.72% | -1.54 33.18% | -11.50 648.93% | -5.66 50.78% | -1.11 80.36% | -6.91 521.72% | -1.91 72.32% | -6.82 256.38% | -24.67K 361,677.07% | |
ev to operating cash flow | -12.61 - | -5.27 58.16% | -1.44 72.73% | -1.66 15.72% | -15.49 830.91% | -7.39 52.30% | -1.11 84.98% | -8.25 643.38% | -2.39 71.03% | -7.39 209.11% | -34.58K 468,013.94% | |
ev to sales | 30.42 - | 80.72K - | ||||||||||
free cash flow per share | -0.60 - | -1.76 192.81% | -1.23 29.92% | -1.00 19.15% | -0.56 43.55% | -0.96 70.35% | -1.47 52.72% | -0.65 55.68% | -0.98 50.63% | -0.96 1.95% | -0.00 99.93% | |
free cash flow yield | -0.07 - | -0.18 168.09% | -0.73 307.63% | -0.58 21.01% | -0.06 89.39% | -0.12 99.14% | -0.75 513.24% | -0.11 84.86% | -0.29 155.81% | -0.15 47.14% | -0.00 99.98% | |
graham net net | 1.26 - | 1.03 17.84% | 1.41 36.74% | 0.07 95.25% | 2.36 3,415.36% | 2.81 19.15% | 2.57 8.58% | 1.97 23.43% | 1.65 16.12% | 0.34 79.42% | 0.00 99.30% | |
graham number | 4.62 - | 8.28 79.32% | 5.24 36.64% | 2.07 60.47% | 6.58 217.18% | 9.12 38.76% | 9.77 7.05% | 5.74 41.25% | 7.41 29.07% | 3.54 52.18% | 0.01 99.78% | |
income quality | 0.84 - | 0.66 21.22% | 1.50 127.04% | 0.88 41.70% | 0.71 18.64% | 0.76 6.29% | 0.95 25.77% | 0.88 7.89% | 0.77 12.05% | 0.79 2.82% | 0.69 13.22% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -11.43 - | -31.80 178.19% | -28.36 10.80% | -19.14 32.53% | -19.75 3.18% | -215.79 992.86% | -33.91 - | -6.25 81.58% | 5.37 185.93% | |||
interest debt per share | 0.37 - | 0.44 16.62% | 0.54 23.83% | 0.43 20.07% | 0.21 52.42% | 0.01 97.17% | 0.03 451.82% | 0.03 21.07% | 0.76 2,911.28% | 1.21 58.11% | -0.00 100.01% | |
inventory turnover | ||||||||||||
invested capital | 0.24 - | 0.33 36.14% | 0.33 1.74% | 2.23 574.99% | 0.07 96.79% | 0.01 - | 0.01 5.92% | 0.39 3,075.03% | 2.51 548.12% | 0.02 99.28% | ||
market cap | 126.58M - | 118.44M 6.43% | 31.94M 73.03% | 40.56M 26.99% | 321.12M 691.64% | 454.95M 41.68% | 131.38M 71.12% | 395.45M 200.98% | 240.17M 39.27% | 550.53M 129.23% | 2.51T 455,558.77% | |
net current asset value | 18.34M - | 13.61M 25.80% | 27.83M 104.56% | 3.11M 88.84% | 84.24M 2,612.30% | 165.23M 96.14% | 183.54M 11.08% | 140.47M 23.47% | 121.72M 13.35% | 32.38M 73.40% | 261.37M 707.33% | |
net debt to ebitda | 2.17 - | 0.23 89.53% | -0.11 148.29% | 0.07 161.09% | 0.64 856.21% | 0.68 6.56% | 0.23 65.98% | 0.50 113.15% | 0.86 72.73% | -0.78 190.60% | 1.98 355.24% | |
net income per share | -0.72 - | -2.65 269.86% | -0.82 68.98% | -1.14 38.45% | -0.79 30.59% | -1.25 58.96% | -1.53 21.53% | -0.71 53.68% | -1.30 84.45% | -1.35 3.92% | -0.00 99.93% | |
operating cash flow per share | -0.60 - | -1.75 191.39% | -1.23 29.58% | -1.00 19.29% | -0.56 43.53% | -0.95 68.96% | -1.46 53.70% | -0.65 55.55% | -0.98 50.52% | -0.96 2.00% | -0.00 99.93% | |
payables turnover | ||||||||||||
receivables turnover | 2 - | |||||||||||
research and ddevelopement to revenue | 1.89 - | 2.60 - | ||||||||||
return on tangible assets | -0.31 - | -0.85 174.80% | -0.36 57.68% | -1.38 282.19% | -0.26 80.81% | -0.39 46.96% | -0.50 27.92% | -0.32 36.34% | -0.46 44.64% | -0.84 83.16% | -0.24 71.08% | |
revenue per share | 0.29 - | 0.00 - | ||||||||||
roe | -0.54 - | -2.30 325.43% | -0.55 76.03% | -6.77 1,126.50% | -0.32 95.21% | -0.43 31.23% | -0.55 28.88% | -0.34 37.84% | -0.70 104.22% | -3.29 372.19% | -0.36 89.04% | |
roic | -0.45 - | -1.04 133.49% | -1.23 17.81% | -2.12 72.24% | -0.19 90.81% | -0.43 119.81% | -0.56 32.06% | -0.34 39.12% | -0.48 41.21% | -0.82 68.54% | -0.34 58.93% | |
sales general and administrative to revenue | 1.24 - | 1.67 - | ||||||||||
shareholders equity per share | 1.32 - | 1.15 13.06% | 1.49 29.41% | 0.17 88.71% | 2.43 1,349.42% | 2.95 21.13% | 2.78 5.70% | 2.07 25.49% | 1.87 9.68% | 0.41 77.99% | 0.00 99.33% | |
stock based compensation to revenue | 0.49 - | 0.49 - | ||||||||||
tangible asset value | 18.60M - | 13.85M 25.52% | 28.11M 103.00% | 3.94M 86.00% | 84.95M 2,057.66% | 170.42M 100.62% | 186.35M 9.35% | 142.71M 23.42% | 132.94M 6.85% | 36.15M 72.80% | 292.26M 708.36% | |
tangible book value per share | 1.32 - | 1.15 13.06% | 1.49 29.41% | 0.17 88.71% | 2.43 1,349.42% | 2.95 21.13% | 2.78 5.70% | 2.07 25.49% | 1.87 9.68% | 0.41 77.99% | 0.00 99.33% | |
working capital | 22.75M - | 16.77M 26.29% | 36.65M 118.53% | 9.22M 74.85% | 87.23M 846.45% | 167.15M 91.61% | 185.29M 10.85% | 141.73M 23.51% | 172.73M 21.88% | 122.63M 29.00% | 366.96M 199.24% |
All numbers in USD (except ratios and percentages)